| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5583257 | Journal of Critical Care | 2017 | 6 Pages |
Abstract
High-dose GIK can be safely used in critically ill patients, though blood glucose and potassium levels must be monitored frequently. GIK was associated with improved CI and blood lactate levels. Impact on survival requires prospective evaluation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Elise M.A. Slob, Rob Shulman, Mervyn Singer,